Who's Really Raising Drug Prices?

Copycat drugmakers are supposed to generate lower prices, but the FTC says that's not how it worked out

In his youth, Billy Grantham worked on rigs in the East Texas oil patch. But ever since a car crash left him blind and disabled, Grantham, 52, has survived on a government payment of less than $1,000 a month. To cope with post-accident trauma, he has relied on a tranquilizer called lorazepam, sold under the brand name Ativan.

One day last May came Grantham's prescription for poverty. He was making his monthly phone call to Heartland, an Omaha, Neb., mail-order pharmacy, when a salesman informed him that the price of lorazepam had jumped from $11 to $85 for a month's supply...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!